Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy

Anna Prigitano, Maria Carmela Esposto, Arianna Biffi, Gabriella De Lorenzis, Vincenza Favuzzi, Raffaella Koncan, Giuliana Lo Cascio, Marisol Barao Ocampo, Carla Colombo, Giovanna Pizzamiglio, Luisa Romanò, Anna Maria Tortorano

Research output: Contribution to journalArticlepeer-review


Background: . Aspergillus fumigatus is frequently recovered from respiratory secretions of cystic fibrosis (CF) patients. Azole resistance has been increasingly reported. Objectives: To assess the prevalence of azole resistance in . A. fumigatus isolates from patients followed by two CF centers of northern Italy. Methods: 423 isolates (220 patients) were screened for azole resistance. Resistance was confirmed with the EUCAST method and . cyp51A gene sequencing. Microsatellite genotyping was performed and results were compared with those of environmental resistant isolates. Results: No resistance was detected in one center, while 8.2% of the patients of the other center harbored resistant isolates. The TR34/L98H alteration in the cyp51A gene, present in seven cases, resulted associated with poor in-vitro activity of all tested azoles. Conclusions: The environmental origin of the resistance seems to be probable since azole resistance was found also in naïve patients and an identical microsatellite genotype in clinical and environmental isolates was observed.

Original languageEnglish
Pages (from-to)64-69
JournalJournal of Cystic Fibrosis
Issue number1
Publication statusPublished - 2017


  • Aspergillus fumigatus
  • Azole resistance
  • Cystic fibrosis
  • Italy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy'. Together they form a unique fingerprint.

Cite this